Member Login
  1. Stocks
    2. /
  2. GSK (LSE: GSK)
    3. /

LSE:GSK (GSK)

About GSK

GlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • GSK (LSE: GSK) Latest News

    Illustration of flames over a black background
    Investing Articles

    Three red hot LSE shares I’d consider buying before the next stock market rally 

    | Harvey Jones

    I'm looking for shares that will lead the next stock market rally and recent performance suggests these three should all…

    Read more »

    Front view photo of a woman using digital tablet in London
    Investing Articles

    2 FTSE 100 dividend stocks! Which should I buy for a second income?

    | Royston Wild

    These UK blue-chip shares are both popular dividend stocks with investors seeking a market-beating second income. Which should I buy…

    Read more »

    pensive bearded business man sitting on chair looking out of the window
    Investing Articles

    2 FTSE 100 value shares I’d buy, and 1 I’d avoid!

    | Royston Wild

    These FTSE 100 shares offer eye-popping value for money. But one of them is still too risky at today's prices,…

    Read more »

    Smiling senior white man talking through telephone while using laptop at desk.
    Investing Articles

    Why now could be the time to buy dirt cheap GSK shares!

    | Royston Wild

    The GSK share price provides excellent all-round value at current levels. I'm looking to add it to my own portfolio…

    Read more »

    A GlaxoSmithKline scientist uses a microscope
    Investing Articles

    Great products and dividends make this FTSE 100 stock look cheap to me

    | Simon Watkins

    Down 9% from its high this year, but with new product approvals and good dividends, this FTSE 100 heavyweight now…

    Read more »

    Middle-aged black male working at home desk
    Investing Articles

    Here’s why I class this blue chip as an exciting value stock!

    | Sumayya Mansoor

    Sumayya Mansoor breaks down this well-known business that she believes falls firmly in the territory of a value stock opportunity…

    Read more »

    Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
    Investing Articles

    Best British value stocks to buy in July

    | The Motley Fool Staff

    We asked our freelance writers to reveal the top value stocks they’d buy in July, all four listed on the…

    Read more »

    Black woman using loudspeaker to be heard
    Investing Articles

    3 dividend stocks I just can’t refuse right now!

    | Dr. James Fox

    With the UK stocks pushing downwards in recent weeks, Dr James Fox explains why he's snapping up some of his…

    Read more »

    Mixed-race female couple enjoying themselves on a walk
    Investing Articles

    Are these 2 FTSE 100 stocks among the best shares to buy today?

    | Zaven Boyrazian, MSc

    These two FTSE 100 stocks are making strides to deliver growth, yet their share prices remain depressed. Is this a…

    Read more »

    A GlaxoSmithKline scientist uses a microscope
    Investing Articles

    Will GSK’s share price spike on Zantac news be sustained?

    | Simon Watkins

    GSK’s share price spiked on news of a settlement over Zantac, but other factors also mean it may continue to…

    Read more »

    Syringe and vial on blue background
    Investing Articles

    3 reasons to buy GSK shares right now?

    | Alan Oscroft

    GSK shares are on a fairly modest valuation at the moment, even though City forecasts for profits and dividends are…

    Read more »

    A GlaxoSmithKline scientist uses a microscope
    Investing Articles

    Down 12% since April, the GSK share price fall looks overdone to me

    | Simon Watkins

    With a raft of new products, healthy dividends and growth prospects, the almost 12% fall in the GSK share price…

    Read more »